1. Home
  2. TCBX vs TBPH Comparison

TCBX vs TBPH Comparison

Compare TCBX & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBX
  • TBPH
  • Stock Information
  • Founded
  • TCBX 2008
  • TBPH 2013
  • Country
  • TCBX United States
  • TBPH United States
  • Employees
  • TCBX N/A
  • TBPH N/A
  • Industry
  • TCBX Banks
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCBX Finance
  • TBPH Health Care
  • Exchange
  • TCBX Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • TCBX 515.0M
  • TBPH 452.3M
  • IPO Year
  • TCBX 2021
  • TBPH N/A
  • Fundamental
  • Price
  • TCBX $35.51
  • TBPH $9.32
  • Analyst Decision
  • TCBX Buy
  • TBPH Buy
  • Analyst Count
  • TCBX 4
  • TBPH 4
  • Target Price
  • TCBX $37.25
  • TBPH $13.75
  • AVG Volume (30 Days)
  • TCBX 81.6K
  • TBPH 202.5K
  • Earning Date
  • TCBX 01-22-2025
  • TBPH 02-26-2025
  • Dividend Yield
  • TCBX N/A
  • TBPH N/A
  • EPS Growth
  • TCBX 40.59
  • TBPH N/A
  • EPS
  • TCBX 2.78
  • TBPH N/A
  • Revenue
  • TCBX $165,678,000.00
  • TBPH $63,192,000.00
  • Revenue This Year
  • TCBX N/A
  • TBPH $11.41
  • Revenue Next Year
  • TCBX $6.73
  • TBPH $37.36
  • P/E Ratio
  • TCBX $12.76
  • TBPH N/A
  • Revenue Growth
  • TCBX 17.16
  • TBPH 15.93
  • 52 Week Low
  • TCBX $18.00
  • TBPH $7.44
  • 52 Week High
  • TCBX $39.06
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • TCBX 44.85
  • TBPH 47.75
  • Support Level
  • TCBX $37.04
  • TBPH $8.85
  • Resistance Level
  • TCBX $38.87
  • TBPH $10.05
  • Average True Range (ATR)
  • TCBX 1.22
  • TBPH 0.38
  • MACD
  • TCBX -0.24
  • TBPH 0.01
  • Stochastic Oscillator
  • TCBX 14.72
  • TBPH 38.75

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: